Table 5.
Average treatment effects: HIV and mental health outcomes
| Outcome | Scale (>) (1) |
Obs (2) |
Control | 1 month ATE | 3 month ATE | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (3) |
SD (4) |
β (5) |
SE (6) |
Δ (7) |
Δ95% (8) |
β (9) |
SE (10) |
Δ (11) |
Δ95% (12) |
|||
| HIV-related outcomes | ||||||||||||
| HIV knowledge | 0–1 (+) | 876 | 0.67 | 0.18 | 0.03 | 0.01* | 0.16 | (0.01 to 0.31) | 0.03 | 0.02 | 0.16 | (−0.06 to 0.38) |
| Sex self-efficacy | 1–5 (+) | 877 | 2.96 | 1.01 | 0.41 | 0.12*** | 0.41 | (0.18 to 0.64) | 0.18 | 0.17 | 0.18 | (−0.16 to 0.51) |
| Sex beliefs | 1–4 (−) | 877 | 1.71 | 0.44 | −0.04 | 0.06 | 0.10 | (−0.36 to 0.16) | −0.04 | 0.08 | 0.10 | (−0.44 to 0.24) |
| Ever vaginal sex | 0–1 (−) | 878 | 0.25 | 0.43 | −0.05 | 0.03 | 0.11 | (−0.25 to 0.02) | −0.01 | 0.05 | 0.03 | (−0.26 to 0.21) |
| High risk sex | 0–1 (−) | 144 | 0.84 | 0.37 | −0.25 | 0.12* | 0.67 | (−1.31 to −0.02) | −0.08 | 0.15 | 0.23 | (−1.02 to 0.56) |
|
| ||||||||||||
| Mental health outcomes | ||||||||||||
| Rosen self-esteem | 0–3 (+) | 878 | 2.15 | 0.40 | 0.02 | 0.06 | 0.06 | (−0.22 to 0.34) | 0.10 | 0.08 | 0.24 | (−0.14 to 0.63) |
| SDQ difficulties | 0–2 (−) | 878 | 0.53 | 0.32 | −0.03 | 0.03 | 0.08 | (−0.27 to 0.10) | −0.00 | 0.04 | 0.01 | (−0.28 to 0.27) |
| CDI depression | 0–2 (−) | 876 | 0.27 | 0.19 | −0.01 | 0.02 | 0.05 | (−0.23 to 0.12) | −0.01 | 0.02 | 0.05 | (−0.29 to 0.18) |
p<0.1,
p<0.05,
p<0.01,
p<0.001
Note. This table reports average treatment effects that are based on a comparison of treatment and control periods. Column 1 lists the scale of each outcome. The character in parentheses indicates the valence of higher values: good (+) or bad (−). Column 2 reports the number of observations across churches and time periods. Columns 3 and 4 report unadjusted means and standard deviations for outcomes at j=1 when all churches were in the control period. Columns 5 to 8 report the results from an OLS regression of each outcome on a combined indicator of 1- and 3-month post-treatment observations, time fixed effects (omitted), community fixed effects (omitted), and a vector of baseline covariates (omitted). Standard errors clustered at the household-level to account for siblings being nested in households. Columns 9 to 12 report the linear combination of the 1-month and marginal 3-month treatment effects. Columns 7 and 11 report Glass’s Δ, a standardized effect size (ATE/control group SD), and columns 8 and 12 report the 95% confidence interval around these effect size estimates. MCG and FCG indicate male and female caregivers, respectively.